NCT04368260View on ClinicalTrials.gov

Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
COVID19
Interventions
DEVICE

Control swab

FDA-cleared nasopharyngeal swab

DEVICE

Prototype swab

Injection molded polypropylene flocked nylon nasopharyngeal swab

Trial Locations (1)

22903

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT04368260 - Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter